Healthcare


COVID-19 portal | Vitamin D | CDC | Vaccine | Keto | W8MD Diet

WikiMD is world's largest health encyclopedia with
28,579 pages, 3,996,643 edits & 34,459,473 views.

Unbiased health & wellness info for free & for all!

Enasidenib

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

Information about Enasidenib

Enasidenib is an orally available small molecule inhibitor of isocitrate dehydrogenase and antineoplastic agent that is used in the therapy of selected cases of acute myeloid leukemia (AML).

Enasidenib
Enasidenib

Liver safety of Enasidenib

Enasidenib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury

Mechanism of action of Enasidenib

Enasidenib (en" a sid' e nib) is a small molecule inhibitor of isocitrate dehydrogenase-2 (IDH2), an enzyme rearranged and mutated in some forms of leukemia and lymphoma.  The mutated IDH2 causes epigenetic alterations that result in a block in myeloid cell differentiation.  Enasidenib has been found to inhibit mutated IDH2 and in several clinical trials was found to induce objective responses in a high proportion of patients with refractory AML who harbored mutant IDH2. 

FDA approval information for Enasidenib

Enasidenib received accelerated approval for use in refractory or relapsed AML with IDH2 mutations in 2017.  Enasidenib is available in tablets of 50 and 100 mg under the brand name IDHIFA. 

Dosage and administration for Enasidenib

The recommended initial dose is 100 mg once daily, continued until progressive disease or intolerable toxicity occurs.  side effects are common and frequently severe (77%), leading to dose interruptions (43%) or discontinuations (17%). 

Side effects of Enasidenib

Common adverse events include diarrhea, nausea and vomiting, abdominal pain, fatigue and anorexia.  Less common but potentially severe side effects include differentiation syndrome, tumor lysis syndrome and embryo-fetal toxicity. 

Alphabetic list of antineoplastic agents - 0-9 - A1 - A2 - A3 - A4 - A5 -A6 - B - C - D - E - F - G - H - I - JK - L - M - NO - PQ - R - S - T - UVW - XYZ

 

Cost and Coupons - Enasidenib

Reviews for Enasidenib

Learn more about Enasidenib

Latest research (Pubmed)

PubMed
Wikipedia

External links


edit 

WikiMD needs you!

This WikiMD article Enasidenib is a stub.
If you are a healthcare professional familiar with the topic Enasidenib, or
A subject matter expert or authority on Enasidenib, you can help us.
About | Mission | Paid editors welcome!

Enasidenib is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever!
Medicine: Health - Encyclopedia‏‎‏‎ - Topics‏‎ -‏‎ Diseases‏‎ - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity‏‎ - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*